Observer variability in the interpretation of HER2/neu immunohistochemical expression with unaided and computer-aided digital microscopy.
暂无分享,去创建一个
Aldo Badano | Marios A Gavrielides | Brandon D Gallas | Petra Lenz | Stephen M Hewitt | P. Lenz | B. Gallas | A. Badano | S. Hewitt | M. Gavrielides
[1] D. Rimm,et al. Automated subcellular localization and quantification of protein expression in tissue microarrays , 2002, Nature Medicine.
[2] K. Berbaum,et al. Satisfaction of search in diagnostic radiology. , 1989, Investigative radiology.
[3] E. Frenkel,et al. Assessment of HER-2/neu status in breast cancer. Automated Cellular Imaging System (ACIS)-assisted quantitation of immunohistochemical assay achieves high accuracy in comparison with fluorescence in situ hybridization assay as the standard. , 2001, American journal of clinical pathology.
[4] Anne Vincent-Salomon,et al. High inter-observer agreement in immunohistochemical evaluation of HER-2/neu expression in breast cancer: a multicentre GEFPICS study. , 2006, European journal of cancer.
[5] Kyle Porter,et al. Semi‐automated imaging system to quantitate Her‐2/neu membrane receptor immunoreactivity in human breast cancer , 2007, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[6] Thomas Rüdiger,et al. Inter‐laboratory and inter‐observer reproducibility of immunohistochemical assessment of the Ki‐67 labelling index in a large multi‐centre trial , 2002, The Journal of pathology.
[7] David L Rimm,et al. Automated Quantitative Analysis of Tissue Microarrays Reveals an Association between High Bcl-2 Expression and Improved Outcome in Melanoma , 2004, Cancer Research.
[8] Yukako Yagi,et al. Digital imaging in pathology: the case for standardization , 2005, Journal of telemedicine and telecare.
[9] Hung Chiang,et al. Interobserver reproducibility of Her-2/neu protein overexpression in invasive breast carcinoma using the DAKO HercepTest. , 2002, American journal of clinical pathology.
[10] H A Lehr,et al. Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis. , 2001, American journal of clinical pathology.
[11] K. Gatter,et al. Immunomicroscopy: A Diagnostic Tool for the Surgical Pathologist , 1995 .
[12] J. Fleiss,et al. Intraclass correlations: uses in assessing rater reliability. , 1979, Psychological bulletin.
[13] Jiang Gu,et al. Virtual microscopy and virtual slides in teaching, diagnosis, and research , 2005 .
[14] Ronald S Weinstein,et al. Innovations in medical imaging and virtual microscopy. , 2005, Human pathology.
[15] David L Rimm,et al. Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome. , 2003, Cancer research.
[16] John J Spinelli,et al. HER-2/neu in Breast Cancer: Interobserver Variability and Performance of Immunohistochemistry with 4 Antibodies Compared with Fluorescent In Situ Hybridization , 2001, Modern Pathology.
[17] J. Baak,et al. Comparing subjective and digital image analysis HER2/neu expression scores with conventional and modified FISH scores in breast cancer , 2007, Journal of Clinical Pathology.
[18] B. Molnár,et al. Digital slide and virtual microscopy based routine and telepathology evaluation of routine gastrointestinal biopsy specimens , 2003, Journal of clinical pathology.
[19] K A Matkowskyj,et al. Quantitative Immunohistochemistry by Measuring Cumulative Signal Strength Using Commercially Available Software Photoshop and Matlab , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[20] Johan Lundin,et al. Virtual microscopy in prostate histopathology: simultaneous viewing of biopsies stained sequentially with hematoxylin and eosin, and alpha-methylacyl-coenzyme A racemase/p63 immunohistochemistry. , 2006, The Journal of urology.
[21] Stephen M Hewitt,et al. Tissue microarrays: bridging the gap between research and the clinic , 2005, Expert review of proteomics.
[22] Kyle J. Myers,et al. Automated Quantitative Assessment of HER-2/neu Immunohistochemical Expression in Breast Cancer , 2009, IEEE Transactions on Medical Imaging.
[23] M Lundin,et al. A digital atlas of breast histopathology: an application of web based virtual microscopy , 2004, Journal of Clinical Pathology.
[24] Richard N. MacLennan,et al. Interrater reliability with SPSS for Windows 5.0 , 1993 .
[25] J Lundin,et al. Virtual microscopy , 2004, Journal of Clinical Pathology.
[26] David J. Foran,et al. Computer-assisted assessment of the Human Epidermal Growth Factor Receptor 2 immunohistochemical assay in imaged histologic sections using a membrane isolation algorithm and quantitative analysis of positive controls , 2008, BMC Medical Imaging.
[27] K. Edmiston,et al. HER-2 Status in Breast Cancer: Correlation of Gene Amplification by FISH With Immunohistochemistry Expression Using Advanced Cellular Imaging System , 2006, Applied immunohistochemistry & molecular morphology : AIMM.
[28] H. Tsuda,et al. Quantitative immunohistochemical evaluation of HER2/neu expression with HercepTestTM in breast carcinoma by image analysis , 2001, Pathology international.
[29] Steven C. Horii. Whole-slide imaging in pathology: the potential impact on PACS , 2007, SPIE Medical Imaging.
[30] R. Forthofer,et al. Rank Correlation Methods , 1981 .
[31] I Vergote,et al. A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group. , 1997, Journal of clinical pathology.
[32] M. Duffy,et al. Objective measurement of breast cancer oestrogen receptor status through digital image analysis. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[33] A Böcking,et al. Interobserver reproducibility of immunocytochemical estrogen- and progesterone receptor status assessment in breast cancer. , 1996, Anticancer research.
[34] J. Papadimitriou,et al. Computerized image analysis of p53 and proliferating cell nuclear antigen expression in benign, hyperplastic, and malignant endometrium. , 2001, Archives of pathology & laboratory medicine.
[35] Anthony Rhodes,et al. Evaluation of HER-2/neu immunohistochemical assay sensitivity and scoring on formalin-fixed and paraffin-processed cell lines and breast tumors: a comparative study involving results from laboratories in 21 countries. , 2002, American journal of clinical pathology.
[36] M. Kendall,et al. The Problem of $m$ Rankings , 1939 .
[37] D. Rimm,et al. Immunohistochemistry and quantitative analysis of protein expression. , 2009, Archives of pathology & laboratory medicine.
[38] T. Seidal,et al. Interpretation and Quantification of Immunostains , 2001, The American journal of surgical pathology.
[39] Alexander von Eye,et al. Analyzing Rater Agreement: Manifest Variable Methods , 2004 .
[40] M. Bonnefoi,et al. Digital Microscopy Imaging and New Approaches in Toxicologic Pathology , 2004, Toxicologic pathology.
[41] K. Bloom,et al. Enhanced accuracy and reliability of HER-2/neu immunohistochemical scoring using digital microscopy. , 2004, American journal of clinical pathology.
[42] Stephen M Hewitt,et al. Perspectives in tissue microarrays. , 2004, Combinatorial chemistry & high throughput screening.
[43] Anthony Rhodes,et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. , 2006, Archives of pathology & laboratory medicine.
[44] P N Furness,et al. The use of digital images in pathology , 1997, The Journal of pathology.